Whose knowledge counts? Involving communities in intervention and trial design using community conversations.
Community conversations
Community engagement
Formative research
Participation
Trials
Under-5 pneumonia
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
07 Jun 2023
07 Jun 2023
Historique:
received:
11
06
2022
accepted:
20
04
2023
medline:
9
6
2023
pubmed:
8
6
2023
entrez:
7
6
2023
Statut:
epublish
Résumé
Current debates in Global Health call for expanding methodologies to allow typically silenced voices to contribute to processes of knowledge production and intervention design. Within trial research, this has typically involved small-scale qualitative work, with limited opportunities for citizens to contribute to the structure and nature of the trial. This paper reports on efforts to move past typical formative trial work, through adaptation of community conversations (CCs) methodology, an action-oriented approach that engages large numbers of community members in dialogue. We applied the CC method to explore community perspectives about pneumonia and managing the health of children under-5 in Northern Nigeria to inform our pragmatic cluster randomised controlled trial evaluating a complex intervention to reduce under-5 mortality in Nigeria. We conducted 12 rounds of community conversations with a total of 320 participants, in six administrative wards in Kiyawa Local Government Area, Jigawa state, our intervention site. Participants were male and female caregivers of children under five. Conversations were structured around participatory learning and action activities, using drawings and discussion to reduce barriers to entry. During activities participants were placed in subgroups: younger women (18-30 years of age), older women (31-49 years) and men (18 years above). Discussions were conducted over three 2-h sessions, facilitated by community researchers. Following an initial analysis to extract priority issues and perspectives on intervention structure, smaller focus group discussions were completed with participants in five new sites to ensure all 11 administrative wards in our study site contributed to the design. We identified enabling and limiting factors which could shape the future trial implementation, including complex power relationships within households and wider communities shaping women's health decision-making, and the gendered use of space. We also noted the positive engagement of participants during the CC process, with many participants valuing the opportunity to express themselves in ways they have not been able to in the past. CCs provide a structured approach to deep meaningful engagement of everyday citizens in intervention and trial designs, but require appropriate resources, and commitment to qualitative research in trials. ISRCTN39213655. Registered on 11 December 2019.
Sections du résumé
BACKGROUND
BACKGROUND
Current debates in Global Health call for expanding methodologies to allow typically silenced voices to contribute to processes of knowledge production and intervention design. Within trial research, this has typically involved small-scale qualitative work, with limited opportunities for citizens to contribute to the structure and nature of the trial. This paper reports on efforts to move past typical formative trial work, through adaptation of community conversations (CCs) methodology, an action-oriented approach that engages large numbers of community members in dialogue. We applied the CC method to explore community perspectives about pneumonia and managing the health of children under-5 in Northern Nigeria to inform our pragmatic cluster randomised controlled trial evaluating a complex intervention to reduce under-5 mortality in Nigeria.
METHODS
METHODS
We conducted 12 rounds of community conversations with a total of 320 participants, in six administrative wards in Kiyawa Local Government Area, Jigawa state, our intervention site. Participants were male and female caregivers of children under five. Conversations were structured around participatory learning and action activities, using drawings and discussion to reduce barriers to entry. During activities participants were placed in subgroups: younger women (18-30 years of age), older women (31-49 years) and men (18 years above). Discussions were conducted over three 2-h sessions, facilitated by community researchers. Following an initial analysis to extract priority issues and perspectives on intervention structure, smaller focus group discussions were completed with participants in five new sites to ensure all 11 administrative wards in our study site contributed to the design.
RESULTS
RESULTS
We identified enabling and limiting factors which could shape the future trial implementation, including complex power relationships within households and wider communities shaping women's health decision-making, and the gendered use of space. We also noted the positive engagement of participants during the CC process, with many participants valuing the opportunity to express themselves in ways they have not been able to in the past.
CONCLUSIONS
CONCLUSIONS
CCs provide a structured approach to deep meaningful engagement of everyday citizens in intervention and trial designs, but require appropriate resources, and commitment to qualitative research in trials.
TRIAL REGISTRATION
BACKGROUND
ISRCTN39213655. Registered on 11 December 2019.
Identifiants
pubmed: 37287035
doi: 10.1186/s13063-023-07320-1
pii: 10.1186/s13063-023-07320-1
pmc: PMC10249250
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
385Subventions
Organisme : GlaxoSmithKline - Save the Children Foundation Partnership
ID : 82603743
Investigateurs
Tahlil Ahmed
(T)
Samy Ahmar
(S)
Christine Cassar
(C)
Adamu Isah
(A)
Adams Osebi
(A)
Abdullahi Magama
(A)
Ibrahim Seriki
(I)
Temitayo Folorunso Olowookere
(TF)
Matt McCalla
(M)
Obioma Uchendu
(O)
Julius Salako
(J)
Damola Bakare
(D)
Omotayo Olojede
(O)
Informations de copyright
© 2023. The Author(s).
Références
Lancet Diabetes Endocrinol. 2019 Mar;7(3):200-212
pubmed: 30733182
Health Educ Behav. 2006 Feb;33(1):25-39
pubmed: 16397157
Pediatr Pulmonol. 2020 Jun;55 Suppl 1:S104-S112
pubmed: 31985894
AIDS Care. 2013;25 Suppl 1:S114-22
pubmed: 23745625
Trials. 2022 Jan 31;23(1):95
pubmed: 35101109
Niger J Med. 2004 Jul-Sep;13(3):276-81
pubmed: 15532232
Int Health. 2009 Sep;1(1):31-6
pubmed: 24036293
Ann N Y Acad Sci. 2014 Jan;1308:54-67
pubmed: 24673167
Lancet. 1978 Dec 16;2(8103):1308
pubmed: 82806
J Eval Clin Pract. 2018 Feb;24(1):240-253
pubmed: 29076631
BMJ Glob Health. 2022 Sep;7(9):
pubmed: 36130778
BMC Public Health. 2017 Dec 11;17(1):944
pubmed: 29228932
BMJ. 2015 Jul 08;351:h3267
pubmed: 26156323
BMC Palliat Care. 2018 Jun 11;17(1):85
pubmed: 29890974
Int J Health Policy Manag. 2014 Sep 25;3(5):283-7
pubmed: 25337602
BMC Public Health. 2013 Apr 17;13:354
pubmed: 23590640
Glob Health Action. 2022 Dec 31;15(1):2120251
pubmed: 36326015
Qual Health Res. 2019 Apr;29(5):623-631
pubmed: 30871431
BMC Public Health. 2017 May 30;17(Suppl 1):397
pubmed: 28699556
Health Policy Plan. 2021 Mar 26;36(2):205-217
pubmed: 33543248
Pimatisiwin. 2010 Fall;8(2):61-88
pubmed: 20975853
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33820807
Milbank Q. 2012 Jun;90(2):311-46
pubmed: 22709390
Diabet Med. 2020 Dec;37(12):2009-2018
pubmed: 32124488
Fam Pract. 2017 Jun 1;34(3):336-340
pubmed: 28334802
BMC Public Health. 2017 Mar 23;17(1):277
pubmed: 28335751
Health Policy Plan. 2014 Sep;29 Suppl 2:ii98-106
pubmed: 25274645
Annu Rev Public Health. 2009;30:1-25
pubmed: 19296774
Qual Health Res. 2016 Nov;26(13):1802-1811
pubmed: 27340178
Niger J Clin Pract. 2019 Nov;22(11):1516-1529
pubmed: 31719273